Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-75229414 |
Trade Name | |
Synonyms | JNJ75229414|JNJ 75229414 |
Drug Descriptions |
JNJ-75229414 comprises T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets KLK2, which potentially induce toxicity against tumor cells expressing KLK2 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C183544 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
JNJ-75229414 | JNJ-75229414 | 0 | 1 |